DDrare: Database of Drug Development for Rare Diseases

76. 下垂体性ゴナドトロピン分泌亢進症
［臨床試験数：25，薬物数：41（DrugBank：11），標的遺伝子数：3，標的パスウェイ数：10］

Searched query = "Pituitary gonadotropin secretion hyperthyroidism", "Gonadotropin secreting pituitary adenoma", "Central precocious puberty", "Gonadotropin producing pituitary adenoma"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Acetate; CPP; Dabu ying pills; Dihuang; Enantone; GnRH; GnRH agonist; Gold; Gonadorelin; Gonadorelin acetate and Triptorelin acetate; Histrelin; Histrelin Subcutaneous Implant; LA; LEUPRORELIN ACETATE; Leuplin; Leuplin DPS 11.25mg; Leuprolide; Leuprolide (GnRH agonists); Leuprolide Acetate (LA); Leuprolide Acetate 3 Month Depot; Leuprolide Acetate 45 mg; Leuprolide acetate 11.25 mg; Leuprolide acetate 30 mg; Leuprolide acetate depot; Leuprorelin; Leuprorelin Acetate 3.75mg Injection; Luphere depot 3.75mg(Leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol Acetate Tablet; Megestrol acetate; RhGH; TRIPTORELIN; Trade name depends on the source of the product; Trade name depends on the source of the product’; Triptorelin; Triptorelin (GnRH agonists); Triptorelin acetate and Gonadorelin acetate; Triptorelin embonate, Triptorelin pamoate; Triptorlin or Leuprorelin; Zhibo dihuang pills; Ziyinxiehuo Granules Herbs

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000038202	2020-09-01	2020-09-13	AMH combined INHB for the diagnosis of female central precocious puberty	AMH combined INHB for the diagnosis of female central precocious puberty	Central precocious puberty	Gold Standard:GnRHa provoctive test;Index test:Anti Mullerian hormone, Inhibin B;	Capital Institute of Pediatrics	NULL	Recruiting	5	8	Female	Target condition:150;Difficult condition:150		China
2	ChiCTR2000034464	2020-09-01	2020-07-05	First Morning Voided Urinary Gonadotropin Measurements for the Early Screening, Diagnosis and Follow-up of CPP Patients	First Morning Voided Urinary Gonadotropin Measurements for the Early Screening, Diagnosis and Follow-up of CPP Patients	Central precocious puberty	Gold Standard:Clinical outcome by CPP diagnostic standards;Index test:morning urine GN;	Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology	NULL	Pending	6	12	Both	Target condition:400;Difficult condition:6000		China

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

ChiCTR2000038202

2020-09-01

2020-09-13

AMH combined INHB for the diagnosis of female central precocious puberty

Central precocious puberty

Gold Standard:GnRHa provoctive test;Index test:Anti Mullerian hormone, Inhibin B;

Capital Institute of Pediatrics

NULL

Recruiting

Female

Target condition:150;Difficult condition:150

China

ChiCTR2000034464

2020-09-01

2020-07-05

First Morning Voided Urinary Gonadotropin Measurements for the Early Screening, Diagnosis and Follow-up of CPP Patients

Central precocious puberty

Gold Standard:Clinical outcome by CPP diagnostic standards;Index test:morning urine GN;

Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

NULL

Pending

Both

Target condition:400;Difficult condition:6000

China